Top compounds associated with response to RPL17-C18orf32


Feature Type Standardized
Nominal ANOVA
mRNA etoposide CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.11 0.0006
mRNA BMS-345541 CTRPv2 pan-cancer AAC 0.14 0.0006
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.12 0.0006
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA AZD8055 CTRPv2 pan-cancer AAC 0.13 0.001
Download CSV